Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
First New Treatment in 50 Years for Asthma Attacks and COPD ‘Could be a Game-Changer’
The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid tablets.
“Game-Changing” New Treatment for Asthma Could Save Millions From Fatal Lung Attacks
A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment failures and improving quality of life. This breakthrough marks a significant advancement after 50 years of stagnant treatment options.
First new asthma attack treatment in 50 years
Researchers say they have found the first new treatment for asthma attacks in 50 years. The injection dampens part of the immune system that can go into overdrive in flare-ups of both asthma and a lung condition called chronic obstructive pulmonary disease (COPD).
Scientists Uncover ‘Game-Changing’ Therapy for Asthma Attacks
The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.
Injections during asthma attacks may be a ‘game-changer’ for sufferers
The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an injection is more effective than the current care of steroid tablets and cuts the need for further treatment by 30 per cent, according to a study.
First treatment in 50 years for serious asthma attacks is ‘game-changer’
Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation.
“Game-Changer” Drug Is First New Asthma Attack Treatment In 50 Years
For the first time in half a century, scientists have hit on a new treatment for asthma attacks. Clinical trial results have shown that a drug called benralizumab is effective at treating acute attacks of both asthma and chronic obstructive pulmonary disease (COPD),
1h
on MSN
Mumbai’s health at risk due to high NO₂ toxic level; 5,400 deaths, increased asthma cases
A report revealed Mumbai's toxic nitrogen dioxide levels exceeded safe limits in 2023. Traffic emissions are the main source.
MedPage Today
2d
Novel Therapies for Asthma in the Pipeline
In this exclusive MedPage Today video, Michael E. Wechsler, MD, a pulmonologist at National Jewish Health in Denver, ...
1d
Exercise during pregnancy may cut a child’s asthma risk in half
Wheezing, shortness of breath, tightness in the chest: the symptoms of an asthma attack can be scary, especially for children ...
earth
5d
First new asthma treatment in 50 years offers hope for millions
The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.
pulmonologyadvisor
12h
Childhood Asthma Disparities by Race/Ethnicity Larger Early On, Taper With Age
Prevalence rates for early childhood asthma in the United States show marked racial/ethnic and socio-economic disparities that taper with age.
The Heritage Foundation
2d
Climate Change, Ozone, and Asthma: Is There a Connection?
Some believe that there is a connection among climate change, ozone in outdoor air, and health effects, including asthma. The U.S. Environmental Protection Agency (EPA) released a report in 2020 ...
2d
on MSN
Revised asthma burden score outperforms current guidelines
A multi-institute collaboration of 26 researchers led by the Mayo Clinic has developed a new asthma burden score that ...
6d
Scientists Develop Whole New Form of Effective Asthma Treatment
Benralizabam, a monoclonal antibody, did a better job than steroids at reducing respiratory symptoms like coughing, wheezing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
benralizumab
Chronic obstructive pulmonary disease
COPD
Feedback